Loading…
Loading…
NORWOOD, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that the Company's Stockholders approved a proposed reverse stock split of the Company's common stock (the “Reverse Stock Split”) at a Special Meeting of Stockholders (the “Special Meeting”) held October 28, 2026.
NORWOOD, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its third quarter 2026 financial results on November 11, 2026 after the markets close.
Envista (NYSE: NVST - Get Free Report) and MariMed (OTCMKTS:MRMD - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and
MariMed's Betty's Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation
NORWOOD, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with a Special Meeting of Stockholders (the “Special Meeting”) to seek stockholder approval of a proposed reverse stock split of the Company's common stock (the “Reverse Stock Split”).
MariMed (OTCMKTS:MRMD - Get Free Report) and NeurAxis (NASDAQ: NRXS - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. Analyst Ratings This is a breakdown of recent ratings
NORWOOD, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced the September 18th opening of Thrive Dispensary Columbus, the Company's 14th Thrive Dispensary location in five states and its second in Ohio.
MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript